Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: A comparative study

GLIA

Volumn 25, Issue 3, 1999, Pages 216-228

  Woodruff, Rachel H ^a   Franklin, Robin J M ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cerebellum; Demyelination; Ethidium bromide; Galactocerebroside; Lysolecithin; Oligodendrocyte; Remyelination; Schwann cell

Indexed keywords

COMPLEMENT; ETHIDIUM; GALACTOSYLCERAMIDE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOTOXIN; LYSOPHOSPHATIDYLCHOLINE;

ANIMAL; ARTICLE; CEREBELLUM; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DEMYELINATING DISEASE; DRUG EFFECT; FEMALE; IMMUNOLOGY; MYELIN SHEATH; OLIGODENDROGLIA; PHYSIOLOGY; RAT; SCHWANN CELL; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

ANIMALS; CEREBELLUM; COMPLEMENT SYSTEM PROTEINS; DEMYELINATING DISEASES; ETHIDIUM; FEMALE; GALACTOSYLCERAMIDES; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOTOXIN; LYSOPHOSPHATIDYLCHOLINES; MYELIN SHEATH; OLIGODENDROGLIA; RATS; RATS, SPRAGUE-DAWLEY; SCHWANN CELLS;

EID: 0033082118     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L     Document Type: Article

References (54)

1. Baron-Van Evercooren A, Clerin-Duhamel E, Lapie P, Gansmuller A, Lachapelle F, Gumpel M. 1992. The fate of Schwann cells transplanted in the brain during development. Dev Neurosci 14:73-84.
2. Baron-Van Evercooren A, Duhamel-Clerin E, Boutry JM, Hauw JJ, Gumpel M. 1993. Pathways of migration of transplanted Schwann cells in the demyelinated mouse spinal cord. J Neurosci Res 35:428-438.
3. Blakemore WF. 1974a. Pattern of remyelination in the CNS. Nature 249:577-578.
4. Blakemore WF. 1974b. Remyelination of the superior cerebellar peduncle in old mice following demyelination induced by cuprizone. J Neurol Sci 22:121-126.
5. Blakemore WF. 1975. Remyelination by Schwann cells of axons demyelinated by intraspinal injections of lysolecithin. J Neurocytol 4:745-757.
6. Blakemore WF. 1976. Invasion of Schwann cells into the spinal cord of the rat following local injections of lysolecithin. Neuropathol App Neurobiol 2:21-39.
7. Blakemore WF. 1978a. Lesions in the cat spinal cord following injection of 6-aminonicotinamide. Res Vet Sci 24:390-391.
8. Blakemore WF. 1978b. Observations on remyelination in the rabbit spinal cord following demyelination induced by lysolecithin. Neuropathol App Neurobiol 4:47-59.
9. Blakemore WF. 1982. Ethidium bromide induced demyelination in the spinal cord of the cat. Neuropathol App Neurobiol 8:365-375.
10. Blakemore WF, Crang AJ. 1985. The use of cultured autologous Schwann cells to remyelinate areas of persistent demyelination in the central nervous system. J Neurol Sci 70:207-223.
11. Blakemore WF, Crang AJ. 1989. The relationship between type-1 astrocytes, Schwann cells and oligodendrocytes following transplantation of glial cell cultures into demyelinating lesions in the adult rat spinal cord. J Neurocytol 18:519-528.
12. Blakemore WF, Eames RA, Smith KJ, McDonald WI. 1977. Remyelination in the spinal cord of the cat following intraspinal injections of lysolecithin. J Neurol Sci 33:31-43.
13. Carroll WM, Jennings AR, Mastaglia FL. 1984. Experimental demyelinating optic neuropathy induced by intra-neural injection of galactocerebroside antiserum. J Neurol Sci 65:125-135.
14. Carroll WM, Jennings AR, Mastaglia FL. 1990. The origin of remyelinating oligodendrocytes in antiserum-mediated demyelinative optic neuropathy. Brain 113:953-973.
15. Dal Canto MC, Melvold RW, Kim BS, Miller SD. 1995. Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection: a pathological and immunological comparison. Microsc Res Tech 32:215-229.
16. Duncan ID. 1996. Glial cell transplantation and remyelination of the central nervous system. Neuropathol App Neurobiol 22:87-100.
17. Dusart I, Isacson O, Nothias F, Gumpel M, Peshanski M. 1989. Presence of Schwann cells in neurodegenerative lesions of the central nervous system. Neurosci Lett 105:246-250.
18. Ferguson B, Matyszak MK, Esiri MM, Perry VH. 1997. Axonal damage in acute multiple sclerosis lesions. Brain 120:393-399.
19. Fraher JP. 1997. Axonal-glial relationships in early CNS-PNS transitional zone development: an ultrastructural study. J Neurocytol 26:41-52.
20. Franklin RJM, Blakemore WF. 1995. Reconstruction of the glia limitans by sub-arachnoid transplantation of astrocyte-enriched cultures. Microsc Res Tech 32:295-301.
21. Franklin RJM. 1997. Repairing CNS demyelination by glial cell transplantation. In: Wekerle H, Graf H, Turner JD, editors. Cellular therapy. Berlin: Springer. p 145-158.
22. Franklin RJM, Blakemore WF. 1993. Requirements for Schwann cell migration within CNS environments: a viewpoint. Int J Dev Neurosci 11:641-649.
23. Franklin RJM, Crang AJ, Blakemore WF. 1991. Transplanted type-1 astrocytes facilitate repair of demyelinating lesions by host oligodendrocytes in adult rat spinal cord. J Neurocytol 20:420-430.
24. Franklin RJM, Crang AJ, Blakemore WF. 1993. The role of astrocytes in the remyelination of glia-free areas of demyelination. Adv Neurol 59:125-133.
25. Franklin RJM, Gilson JM. 1996. Remyelination in the CNS of the hypothyroid rat. NeuroReport 7:1526-1530.
26. Franklin RJM, Gilson JM, Blakemore WF. 1997. Local recruitment of remyelinating cells in the repair of demyelination in the central nervous system. J Neurosci Res 50:337-344.
27. Gensert JM, Goldman JE. 1997. Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron 19:197-203.
28. Ghirnikar RS, Eng LF. 1994. Astrocyte-Schwann cell interactions in culture. Glia 11:367-377.
29. Gilson J, Blakemore WF. 1993. Failure of remyelination in areas of demyelination produced in the spinal cord of old rats. Neuropathol App Neurobiol 19:173-181.
30. Godfraind C, Friedrich VL, Holmes KV, Dubois-Dalcq M. 1989. In vivo analysis of glial cell phenotypes during a viral demyelinating disease in mice. J Cell Biol 109:2405-2416.
31. Golding J, Shewan D, Cohen J. 1997. Maturation of the mammalian dorsal root entry zone - from entry to no entry. Trends Neurosci 20:303-308.
32. Grinspan JB, Stern J, Franceschini B, Yasuda T, Pleasure D. 1994. Protein growth factors as potential therapies for central nervous system demyelinative disorders. Ann Neurol 36 Suppl.:S140-S142
33. Guazzo EP, Franklin RJM, Blakemore WF. 1995. A rat spinal subarachnoid continuous infusion device. J Clin Neurosci 2:339-344.
34. Hall SM. 1972. The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord. J Cell Sci 10:535-546.
35. Harrison BM, McDonald WI, Ochoa J, Sears TA. 1970. Electron microscopic observations on a focal experimental demyelinating lesion in the cat spinal cord. J Neurol Sci 10:409-413.
36. Jeffery ND, Blakemore WF. 1995. Remyelinaion of mouse spinal cord axons demyelinated by local injection of lysolecithin. J Neurocytol 24:775-781.
37. Jeffery, ND, Blakemore WF. 1997. Locomotor deficits induced by experimental spinal cord demyelination are abolished by spontaneous remyelination. Brain 120:27-37.
38. Keirstead HS, Blakemore WF. 1997. Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord. J Neuropathol Exp Neurol 56:1191-1201.
39. McDonald WI, Sears TA. 1970. Focal experimental demyelination in the central nervous system. Brain 93:575-582.
40. McKay JS, Blakemore WF, Franklin RJM. 1997. The effects of the growth factor-antagonist, trapidil, on remyelination in the CNS. Neuropathol App Neurobiol 23:50-58.
41. McMorris FA, Mckinnon RD. 1996. Regulation of oligodendrocyte development and CNS myelination by growth factors: prospects for therapy of demyelinating disease. Brain Pathol 6:313-329.
42. Meeson AP, Piddlesden S, Morgan BP, Reynolds R. 1994. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis. Exp Neurol 129:299-310.
43. Miller DJ, Rodriguez M. 1996. Spontaneous central nervous system remyelination in strain A mice after infection with the Daniel's (DA) strain of Theiler's virus. Acta Neuropathol (Berl.) 91:559-565.
44. Palmer AC, Jackson PG, Blakemore WF. 1991. A primary demyelinating disorder of young cattle. Neuropathol Appl Neurobiol 17:457-467.
45. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates. 2nd ed. San Diego: Academic Press.
46. Raine CS, Snyder DH, Valsamis MP, Stone SH. 1974. Chronic experimental allergic encephalomyelitis in inbred guinea pigs. Lab Invest 31:369-380.
47. Sasaki M, Ide C. 1989. Demyelination and remyelination in the dorsal funiculus of the rat spinal cord after heat injury. J Neurocytol 18:225-239.
48. Shi J, Marinovich A, Barres BA. 1998. Purification and characterization of adult oligodendrocyte precursor cells from the rat optic nerve. J Neurosci 18:4627-4636.
49. Smith KJ, Blakemore WF, McDonald WI. 1979. Central remyelination restores secure conduction. Nature 280:395-396.
50. Smith KJ, Hall SM. 1994. Central demyelination induced in vivo by the calcium ionophore ionomycin. Brain 117:1351-1356.
51. Trapp B, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö, L. 1998. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278-285.
52. Waxman SG, Kocsis JD, Nitta KC. 1979. Lysophosphatidyl choline-induced focal demyelination in the rabbit corpus callosum: light-microscopic observations. J Neurol Sci 44:45-53.
53. Williams LR, Vahlsing HL, Lindamood T, Varon S, Gage FH, Manthorpe M. 1987. A small gauge cannula device for continuous infusion of exogenous agents into the brain. Exp Neurol 95: 743-754.
54. Woodruff RH, Franklin RJM. 1997. Growth factors and remyelination in the CNS. Histol Histopathol 12:459-466.